Background/Objective: Normally sited glands account for increasing congenital hypothyroidism (CH). Mechanisms often remain unknown. To report the incidence of CH with in situ thyroid gland (ISTG) and describe the natural history of the disease without known etiology. Method: Clinical, biochemical and imaging data at diagnosis were retrospectively analyzed in 285 children positively screened for CH in Ile-de-France between 2005 and 2008. If treatment was discontinued, management of hormonal substitution and follow-up of biochemical thyroid function was performed. Results: 93 full-term CH neonates displayed ISTG (40.6%), including 50 with unexplained mechanism. Follow-up data were available in 32 of them. Therapy was withdrawn from 20 children at a median age of 23.5 months (6-66), among whom 18 remained still untreated over a median duration of 15.3 months (4.4-29.6). In 11 children, levothyroxine (L-T4) dosage was increased over time to maintain biochemical euthyroidism. No statistical differences in initial TSH or FT4 levels, iodine status or birth weight were found between children with transient and permanent hypothyroidism. Conclusion: Withdrawal of L-T4 substitution was feasible in 56.2% of full-term children with CH with ISTG but unexplained mechanism, emphasizing the need for systematic therapy withdrawal. However, further studies are warranted to standardize withdrawal protocol.

Keywords:
Congenital hypothyroidism, Thyroid gland, Transient hypothyroidism
1.
Albert BB, Cutfield WS, Webster D, Carll J, Derraik JG, Jefferies C, Gunn AJ, Hofman PL: Etiology of increasing incidence of congenital hypothyroidism in New Zealand from 1993 to 2010. J Clin Endocrinol Metab 2012;97:3155-3160.
2.
Pearce MS, Korada M, Day J, Turner S, Allison D, Kibirige M, Cheetham TD: Increasing incidence, but lack of seasonality, of elevated TSH levels, on newborn screening, in the north of England. J Thyroid Res 2010;2010:101948.
3.
Harris KB, Pass KA: Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007;91:268-277.
4.
Hinton CF, Harris KB, Borgfeld L, Drummond-Borg M, Eaton R, Lorey F, Therrell BL, Wallace J, Pass KA: Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 2010;125(suppl 2):S37-S47.
5.
Shapira SK, Lloyd-Puryear MA, Boyle C: Future research directions to identify causes of the increasing incidence rate of congenital hypothyroidism in the United States. Pediatrics 2012;125(suppl 2):S64-S68.
6.
Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernichow P, Leger J: Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;86:2009-2014.
7.
Mitchell ML, Hsu HW, Sahai I: The increased incidence of congenital hypothyroidism: fact or fancy? Clin Endocrinol (Oxf) 2011;75:806-810.
8.
Deladoey J, Ruel J, Giguere Y, Van Vliet G: Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Quebec. J Clin Endocrinol Metab 2011;96:2422-2429.
9.
Gaudino R, Garel C, Czernichow P, Leger J: Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf) 2005;62:444-448.
10.
Cavarzere P, Castanet M, Polak M, Raux-Demay MC, Cabrol S, Carel JC, Leger J, Czernichow P: Clinical description of infants with congenital hypothyroidism and iodide organification defects. Horm Res 2008;70:240-248.
11.
Eugster EA, LeMay D, Zerin JM, Pescovitz OH: Definitive diagnosis in children with congenital hypothyroidism. J Pediatr 2004;144:643-647.
12.
Kemper AR, Ouyang L, Grosse SD: Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data. BMC Pediatr 2010;10:9.
13.
Rabbiosi S, Vigone MC, Cortinovis F, Zamproni I, Fugazzola L, Persani L, Corbetta C, Chiumello G, Weber G: Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab 2013;98:1395-1402.
14.
Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group: European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism. Horm Res Paediatr 2014;81:80-103.
15.
LaFranchi SH: Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis 2010;33:S225-S233.
16.
Hashemipour M, Hovsepian S, Kelishadi R, Iranpour R, Hadian R, Haghighi S, Gharapetian A, Talaei M, Amini M: Permanent and transient congenital hypothyroidism in Isfahan-Iran. J Med Screen 2009;16:11-16.
17.
Korzeniewski SJ, Grigorescu V, Kleyn M, Young WI, Birbeck G, Todem D, Romero R, Paneth N: Transient hypothyroidism at 3-year follow-up among cases of congenital hypothyroidism detected by newborn screening. J Pediatr 2013;162:177-182.
18.
Weber G, Vigone MC, Passoni A, Odoni M, Paesano PL, Dosio F, Proverbio MC, Corbetta C, Persani L, Chiumello G: Congenital hypothyroidism with gland in situ: diagnostic re-evaluation. J Endocrinol Invest 2005;28:516-522.
19.
Parks JS, Lin M, Grosse SD, Hinton CF, Drummond-Borg M, Borgfeld L, Sullivan KM: The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics 2010;125(suppl 2):S54-S63.
20.
O'Grady MJ, Cody D: Subclinical hypothyroidism in childhood. Arch Dis Child 2012;96:280-284.
21.
Wasniewska M, Corrias A, Aversa T, Valenzise M, Mussa A, De Martino L, Lombardo F, De Luca F, Salerno M: Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism. Horm Res Paediatr 2012;77:376-381.
22.
Maruo Y, Takahashi H, Soeda I, Nishikura N, Matsui K, Ota Y, Mimura Y, Mori A, Sato H, Takeuchi Y: Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J Clin Endocrinol Metab 2008;93:4261-4267.
23.
Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, Vulsma T, Ris-Stalpers C: Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95-102.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.